Latest market price
10.76
-0.28-2.54%
OverviewShort InterestFilings
KROSQT50Keros Therapeutics, Inc.·NASDAQ
10.76-2.54%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 29, 20268-KCurrent report
Sep 28, 20268-KCurrent report
Sep 16, 2026EFFECTNotice of effectiveness
Sep 11, 2026DEL AMDEL AM
Sep 10, 2026S-3Shelf registration statement
Sep 08, 20268-KCurrent report
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 18, 2026144Notice of proposed sale of restricted securities
Aug 13, 20263Initial statement of beneficial ownership
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Aug 03, 20268-KCurrent report
Jul 30, 20268-KCurrent report
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 22, 20268-KCurrent report
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 2026SC 13GBeneficial ownership statement (passive)
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jun 25, 20268-KCurrent report
#1 / 25 of 383
Page
▼
/ 16